Table 2. Clonality detection overall and in myTYPE positive patients.

	All (n = 177)	Smoldering multiple myeloma (n = 26)	Newly diagnosed multiple myeloma (n = 104)	Relapsing/ refractory multiple myeloma (n = 47)
Clonality overall	144 (81%)	19 (73%)	84 (81%)	41 (87%)
myTYPE positive	76/169 (45%)	7/24 (29%)	42/98 (43%)	27/47 (57%)
Clonality in myTYPE pos	72 (95%)	6 (86%)	42 (100%)	24 (89%)

V(D)J sequencing was done on all samples; myTYPE was done on all samples with sufficient remaining DNA. Numbers and percentages of positive calls are shown for the whole cohort as well as subgroups.